Add Row
Add Element
cropper
update
[Company Name]
Concierge Health Hub logo
update
Add Element
  • Home
  • Categories
    • Practice Mastery
    • Patient Connect
    • Financial Fitness
    • Tech Advantage
    • Marketing Mastery
    • Regulatory Radar
    • Wellness Wisdom
Add Row
Add Element
June 29.2025
3 Minutes Read

Discover How PillTrek Revolutionizes GI Health Monitoring for Practitioners

Smart capsule diagram tracking GI tract health, infographic style.

PillTrek: A Breakthrough in GI Health Monitoring

The gastrointestinal (GI) tract is often an overlooked facet of health, playing a crucial role in processes such as digestion, hormone production, and even neurotransmitter release that can affect our mood and brain function. The advent of new technologies designed to assess gut health is transforming how health practitioners support their patients, and at the forefront of this revolution is an innovative smart capsule developed by engineers at the California Institute of Technology.

The Importance of Monitoring GI Health

Understanding the health of the GI tract has become increasingly vital as scientists acknowledge its influence on overall health. Traditional methods for evaluating GI conditions—like fecal analysis or biopsies—tend to be invasive, expensive, and often fail to provide real-time data. In contrast, the PillTrek capsule presents a non-invasive and innovative solution for continuous monitoring of the GI tract.

How PillTrek Works

PillTrek is a miniaturized electrochemical platform capable of measuring various biomarkers in the GI tract. Its unique design incorporates low-power electronics and simple sensors, making it an affordable option that can conduct ongoing assessments of pH, temperature, and various metabolites. Measuring 7 millimeters in diameter and 25 millimeters in length, it is smaller than conventional capsule cameras used in endoscopy, yet boasts the ability to deliver a comprehensive assortment of electrochemical measurements.

Applications and Future Potential

According to Wei Gao, a professor of medical engineering at Caltech, PillTrek represents a significant advancement in our ability to routinely analyze gut health. Its reconfigurable electrochemical workstation means that various sensors can be integrated seamlessly, allowing it to measure not just glucose and temperature but also vital neurotransmitters like serotonin and dopamine, as well as other hormones. Such capabilities open up possibilities for personalized medicine, allowing health practitioners to monitor biomarkers specific to individual patients while effectively gauging their GI health.

Why This Matters to Health Practitioners

As concierge health practitioners facing a rapidly evolving medical landscape, staying informed about the latest advancements in technology like PillTrek can be invaluable. Understanding such innovations can enhance the level of care practitioners offer their patients, improve treatment strategies, and lead to better health outcomes overall. Considering the impact of GI health on conditions such as obesity, diabetes, and mental health, adopting real-time monitoring technologies will be crucial for future patient management strategies.

Looking Forward: The Future of GI Monitoring

The implications of smart capsule technology like PillTrek extend beyond mere diagnostics. The potential for these devices to enable preventive healthcare and personalized treatment makes them especially advantageous in modern medical practice. With the ongoing development of PillTrek and similar technologies, we may soon witness a transition in how GI health is monitored, ushering in an era where practitioners can track and respond to gut health in real time, ultimately enhancing their patients' quality of life.

Call to Action: Staying Ahead of the Curve

As the landscape of healthcare technology continues to evolve, it's imperative for health practitioners, especially those in concierge medicine, to stay informed of advancements like PillTrek. By integrating these smart technologies into your practice, not only can you enhance patient care, but you also position yourself as a leader in adopting innovative health solutions. Explore ways to incorporate such technologies into your practice to elevate your patient outcomes.

Tech Advantage

Write A Comment

*
*
Related Posts All Posts
06.29.2025

Could a Blood Test Replace Bone Marrow Sampling for Leukemia Risk Detection?

Update Revolutionizing Cancer Diagnosis with Blood Tests For decades, diagnosing blood cancers like leukemia has relied heavily on invasive procedures like bone marrow sampling. However, recent research from the Weizmann Institute of Science points towards a new approach that could significantly change this landscape. Imagine a simple blood test that provides insights into not just blood disorders, but a more comprehensive view of an individual’s health trajectory. This article explores the promising developments in blood testing and what they mean for health practitioners and their patients. A Breakthrough in Understanding Aging and Health The research teams led by Professors Liran Shlush and Amos Tanay have delved deeply into the biology of blood stem cells, with a focus on how these cells change as we age. Their findings reveal that approximately one-third of individuals over 40 exhibit genetic alterations in these cells. Such changes significantly increase the likelihood of developing blood cancers like leukemia, along with other conditions like heart disease and diabetes. This understanding is crucial, especially for practitioners who want to implement more preventative measures for their patients. Understanding Myelodysplastic Syndrome (MDS) Myelodysplastic syndrome (MDS) is a critical area where this research is making strides. MDS prevents blood stem cells from maturing correctly, often leading to severe anemia and a heightened risk for acute myeloid leukemia. Traditional diagnostic measures can cause discomfort to patients and delay treatment. The new blood test, developed by Dr. Nili Furer and her team, potentially circumvents these issues by analyzing rare blood stem cells that migrate into the bloodstream. This finding underscores the transition to less invasive diagnostic procedures, offering a win-win for both patients and healthcare providers. The Technology: Advanced Single-Cell Genetic Sequencing This innovative blood test leverages advanced single-cell genetic sequencing to isolate and analyze the genetic profile of circulating blood stem cells. With this technology, the research team developed a method that allows for the identification of early signs of blood disorders and can even project future risks—information that could be vital for proactive patient management. As healthcare technology continues to integrate into everyday practice, understanding these emerging tools will empower concierge health practitioners to better serve their patients. The Gender Gap in Blood Cancer Prevalence A surprising element of the research indicates that the changes in blood stem cell populations occur earlier in males than females, which may explain why men face a higher prevalence of blood cancers. This gender disparity is important for practitioners to consider when screening and educating their patients about their health risks. Highlighting these differences can enhance patient care and lead to earlier interventions where necessary. Current and Future Applications of Blood Testing The implications of this study extend beyond just MDS and leukemia; the research suggests potential applications for a range of other blood-related disorders. This broad spectrum of capabilities signals an exciting future for non-invasive diagnostics. Participating in large-scale clinical trials could further validate and refine these tests, adding more tools to the healthcare practitioner’s arsenal. Reflections and Call to Action As concierge practitioners seek proactive measures to enhance patient care, staying informed about advances in medical technology is essential. Understanding how blood tests can help forecast patient health and manage chronic conditions can lead to better outcomes. Engaging in discussions, attending seminars, and integrating novel diagnostic tools like this blood test into practice can position healthcare providers at the forefront of patient care innovation. As a community, let’s advocate for these advancements to ensure our patients have the best possible outcomes.

06.29.2025

How Precision Oncology Can Predict Chemotherapy Effectiveness in Esophageal Cancer

Update Revolutionizing Esophageal Cancer Treatment with Precision OncologyIn the fight against esophageal adenocarcinoma (EAC), a deadly form of cancer affecting thousands each year, traditional chemotherapy has long been a go-to option despite its limitations. Recent breakthroughs in precision oncology may drastically change the way we approach treatment for this disease. A pioneering collaboration led by researchers at Harvard University's Wyss Institute has developed a novel platform that can predict the effectiveness of chemotherapy based on individual patient profiles, offering hope where there once was none.Understanding Esophageal Adenocarcinoma: The Need for PrecisionEsophageal cancer is the sixth most lethal cancer globally, with EAC being one of its two primary forms. Currently, patients often undergo neoadjuvant chemotherapy (NACT) to shrink tumors before surgery, yet many experience resistance, leading to poor outcomes and unnecessary side effects. The absence of targeted therapies exacerbates the problem, placing the need for personalized approaches center stage. The traditional models often fail to account for the complexity of a patient’s unique tumor microenvironment (TME), thus yielding misleading results.Introducing the Cancer Chip: A Game ChangerThe breakthrough is the Cancer Chip, a patient-specific model that incorporates actual tumor cells and associated stromal cells. This cutting-edge technology allows researchers to closely simulate the TME within a microfluidic system. By co-culturing the EAC organoids alongside stromal cells isolated from the same patient, they can create realistic models that reflect how individual tumors respond to various chemotherapy agents. This is a significant improvement over the previous organoid models, which lacked these essential components.How It Works: The Science of Simulated ResponsesThe Cancer Chip system utilizes advanced microfluidic technology to create an environment mimicking the cellular and molecular structure of the tumor. Researchers can apply different chemotherapy treatments directly onto the chip and observe how the organoids react in real time. This process offers invaluable insights into which treatments are most likely to be effective for each specific patient, ultimately guiding clinical decisions.Implications for Concierge Health PractitionersFor concierge health practitioners, staying at the forefront of such innovations is essential for better patient care. The ability to offer personalized treatment plans based on accurate predictions can significantly improve treatment outcomes while minimizing the toxic effects associated with chemotherapy. This technology not only empowers practitioners to make informed decisions but also enhances patient satisfaction and trust.Future Trends and Predictions in Cancer TreatmentThe rise of precision oncology is paving the way for a more personalized approach in medicine. As technology continues to evolve, we can expect further integration of AI and machine learning in personalized treatment options. Ensuring patient-specific insights will become the gold standard for treatment protocols in the near future, leading to better, tailored cancer therapies.Conclusion: Embracing ChangeThe Cancer Chip signifies a monumental shift in how we tackle aggressive cancers like EAC. By understanding each patient’s unique cancer response, healthcare professionals can tailor treatments that genuinely meet individual needs, essentially eliminating the guesswork from chemotherapy treatment plans. As concierge health practitioners, engaging with these advancements ensures patients receive the highest standard of care, promoting better health outcomes.

06.29.2025

Bridging the Gap: Language Barriers in CGM Prescription Disparities

Update A Language Divide in Health: Understanding Disparities in CGM Prescriptions The emergence of continuous glucose monitors (CGMs) marks a significant advancement in diabetes management, enabling real-time monitoring for patients with type 2 diabetes (T2D). However, a recent study from JAMA Network Open highlights a concerning trend: disparities in CGM prescriptions based on language preference. The research reveals that patients with non-English language preference (NELP) are experiencing significantly reduced access to these vital devices compared to their English-speaking counterparts. The Impact of Language Preference on Healthcare Access Conducted by a team from Brigham and Women's Hospital, the study analyzed data from a substantial cohort of 69,269 adults with T2D who were receiving medical care between January 2022 and December 2023. Alarmingly, only 12.1% of these patients preferred a language other than English. Within this population, the data showed that only 7.4% of NELP patients received a CGM prescription, compared to 12.7% of those with English language preference. This disparity suggests that language barriers may influence healthcare providers' prescribing practices and, consequently, the health outcomes of patients. Examining the Statistical Disparity The study's adjusted odds ratio revealed that patients with NELP were significantly less likely to receive a CGM prescription, with an aOR of 0.58, meaning they had less than a 60% chance of obtaining one compared to ELP patients. This statistic evokes critical questions about the systemic biases that may exist within healthcare settings. The sensitivity analyses also revealed persistent discrepancies, particularly in patients with uncontrolled diabetes and those using insulin. For instance, patients with an A1c level greater than 9% and NELP still had lower odds of receiving a CGM compared to their ELP peers. Historical Context: The Journey of Diabetes Management Understanding these disparities requires a look into the history and evolution of diabetes monitoring technologies. The advent of CGMs has transformed the management strategies for patients with T2D, allowing for continuous oversight and better glucose control. However, the introduction of this technology also necessitates equitable access and understanding across diverse populations. Encountering Barriers: The Emotional Toll on Patients The implications of these findings extend beyond mere statistics; they touch on the emotional and psychological struggles that accompany diabetes management. For patients with NELP, the added burden of navigating a healthcare system that may not fully accommodate their language and cultural needs can be disheartening. This sense of alienation can lead to decreased engagement with healthcare providers and a rise in complications related to diabetes. Future Predictions: Bridging the Language Gap As healthcare continues to evolve towards personalized medicine, it's crucial for practitioners to remain vigilant against these disparities. Future predictions suggest a growing emphasis on integrating language services and cultural competency training within healthcare organizations. This shift may help bridge the divide for patients with NELP, ensuring equitable access to emerging technologies like CGMs. Decisions You Can Make To Improve Patient Care For concierge health practitioners, the findings from this study should inform clinical decision-making. Implementing routine language assessments can help identify patients who may require additional resources. Establishing partnerships with translation services can also facilitate smoother communication and improve the quality of care delivered to all patients, regardless of their language preference. Actionable Insights: Steps Toward Equity To address these disparities, healthcare providers should consider the following actionable strategies: Prioritize cultural competency training within your practice. Utilize translation services during consultations and follow-ups. Engage community organizations that serve non-English speaking populations to promote wellness programs. These steps are essential for building an inclusive healthcare environment that recognizes and addresses the barriers faced by all patients. Conclusion: Taking a Stand Against Disparities The findings regarding language-based disparities in CGM prescriptions are a wake-up call to healthcare providers. It's crucial to advocate for equitable access to diabetes management technologies. As you consider the implications of these disparities, reflect on the importance of language inclusivity in your practice. Together, we can create a healthcare model that is not just effective, but equitable for all. In light of these insights, I urge you to evaluate your own practices and explore ways to ensure your patients receive the technology and support they need—regardless of language preferences.

Add Row
Add Element
cropper
update
MYBRANDINGLOGO
Concierge Health Hub logo
update

Concierge Health Hub is a popular free resource for concierge medical practices in the English-speaking world, providing insights into everything from connecting with your patients, to marketing, to regulatory rules.

  • Concierge Health Hub Facebook Page URL
    update
  • update
  • update
  • update
  • update
  • update
  • update
Add Element

NEED TO CONTACT US?

If you have any enquiries, contact us now and we will get back to you as soon as possible.

Setup Your Button

   CONTACT US   

{"name":"Contact Us","action_type":"2","optin_action_type":"5","form_redirect_type":"2","form_redirect_custom_url":"","order_form_settings":{"containers":[{"id":"personal-info-wrapper","visible":true,"label":{"id":"of-personal-title","visible":true},"fields":[{"id":"of-full-name","setting":false,"placeholder":"Full Name"},{"id":"of-field-email","setting":false,"placeholder":"Email Address"},{"id":"of-phone-number","setting":true,"visible":false,"require":true,"placeholder":"Enter Your Mobile Phone","additional":{"sms_permission":0}},{"id":"of-gdpr-optin-approval","label":"I Accept To Receive Additional Info","placeholder":"","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"gdpr_optin_approval":"1"}}]},{"id":"shipping-information-wrapper","visible":false,"label":{"id":"of-shipping-title","visible":true},"fields":[{"id":"of-shipping-address","setting":false,"placeholder":"Address"},{"id":"of-shipping-city","setting":false,"placeholder":"City"},{"id":"of-shipping-state","setting":false,"placeholder":"State"},{"id":"of-shipping-zipcode","setting":false,"placeholder":"Postal Code"}]},{"id":"profit-bump-wrapper","visible":true,"otoBgColor":"rgba(219,229,239,1)","otoBorderColor":"rgba(38,71,102,1)","otoTitleBgColor":"rgba(45,78,108,1)","otoArrowsColor":"rgba(255,177,58,1)","fields":[]},{"id":"order-summary-wrapper","visible":true,"orderDynamicBgColor":"rgba(242,242,242,1)","orderDynamicTexColor":"rgba(51,51,51,1)","fields":[]}]},"optin_type":{"showLabels":0,"fields":[{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"last_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"email","label":"Email","placeholder":"Enter Your Email","icon":"fa-envelope","required":1,"visible":1,"system":1,"additional":{}},{"name":"mobile_phone","label":"Mobile Phone","placeholder":"Enter Your Mobile Phone","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"sms_permission":0}},{"name":"fields_labels","label":"","placeholder":"","icon":"","required":0,"visible":1,"system":1,"additional":{}},{"name":"captcha","label":"Captcha","placeholder":"","icon":"","required":1,"visible":1,"system":1,"additional":{}},{"name":"gdpr_optin_approval","label":"SSBBY2NlcHQgVG8gUmVjZWl2ZSBBZGRpdGlvbmFsIEluZm8=","placeholder":"","icon":"fa-mobile","required":0,"visible":1,"system":1,"additional":{"gdpr_optin_approval":"1","sms_permission":0}}],"customFields":[],"sortedFields":[{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"last_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"email","label":"Email","placeholder":"Enter Your Email","icon":"fa-envelope","required":1,"visible":1,"system":1,"additional":{}},{"name":"mobile_phone","label":"Mobile Phone","placeholder":"Enter Your Mobile Phone","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"sms_permission":0}},{"name":"captcha","label":"Captcha","placeholder":"","icon":"","required":1,"visible":1,"system":1,"additional":{}}],"design":{"form_background_color":"rgb(245, 245, 245)","field_stroke":{"size":"1","color":"rgb(220, 220, 220)"},"field_icons":1,"button_color":"rgb(255, 158, 0)","button_stroke":{"size":"0","color":"rgba(255, 255, 255, 0.2)"},"button_box_shadow_color":"none","field_size":"small","label_size":"16","label_color":"rgb(0, 0, 0)","input_color":"rgb(52, 152, 219)","control_text_color":"rgb(0, 0, 0)","control_text_size":"15"},"mappedFields":[]},"redirect_type":{"url":"","target":0},"next_step":{},"click_to_email":{"value":"info@banidadigital.com"},"click_to_call":{"value":""},"jump_to_block":{},"content":{"header_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZToyNHB4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDoxLjRlbTsiPldlIEFyZSBFeGNpdGVkITwvc3Bhbj48L3NwYW4+","content_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZTo0OHB4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDowLjllbTsiPjxzdHJvbmc+UExFQVNFIEZJTEwgT1VUIFlPVVIgSU5GTyAgQkVMT1cgVE8gU1VCU0NSSUJFPC9zdHJvbmc+PC9zcGFuPjwvc3Bhbj4=","button_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZToyN3B4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDoxZW07Ij48c3Ryb25nPlNFQ1VSRSBNWSBTUE9UPC9zdHJvbmc+PC9zcGFuPjwvc3Bhbj4=","spam_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuMmVtOyI+V2UgaGF0ZSBTUEFNIGFuZCBwcm9taXNlIHRvIGtlZXAgeW91ciBlbWFpbCBhZGRyZXNzIHNhZmU8L3NwYW4+","sms_text":"UmVjZWl2ZSBTTVMgVGV4dCBVcGRhdGVzIC0gPHNwYW4+b3B0aW9uYWw8L3NwYW4+","sms_text2":"SSBBY2NlcHQgVG8gUmVjZWl2ZSBBZGRpdGlvbmFsIEluZm8="},"email_confirmation":{"enable":1,"subject":"V2UgQXJlIEV4Y2l0ZWQhIFlvdXIgSW4h","message":""},"integrations":[],"automation_enable":0,"thank_you":{"type":"popup","redirect_url":"","popup_options":{"background_color":"#ffffff","headline_visible":1,"icon_visible":1,"icon_url":"//my.funnelpages.com/assets-pb/images/thankyou-popup-icon.png","subheadline_visible":1,"button_visible":1,"button_color":"#ffa800","headline_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuNGVtOyI+VGhhbmsgWW91IEZvciBDb250YWN0aW5nIFVzPC9zcGFuPg==","subeadline_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuNGVtOyI+UGxlYXNlIENoZWNrIFlvdXIgRW1haWw8YnIgLz5XZSBXaWxsIEJlIEZvbGxvd2luZyBVcCBTaG9ydGx5PC9zcGFuPg==","button_text":"Q2xvc2U="}}}
Add Element

© 2025 Alicorn Ventures, LLC All Rights Reserved. 30 N. Gould Ste R, Sheridan, WY 82801 . Contact Us . Terms of Service . Privacy Policy

{"company":"Alicorn Ventures, LLC","address":"30 N. Gould Ste R","city":"Sheridan","state":"WY","zip":"82801","email":"info@banidadigital.com","tos":"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","privacy":"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"}

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*